The proto-oncogene c-ets is exceptional in two respects. First, its viral counterpart is part of the genome of an unusual acute avian leukaemia virus, E26, that contains a tripartite transforming gene consisting of the viral gag gene linked to v-myb and v-ets sequences (Leprince et al., 1983; Nunn et al., 1983) . Second, in the human (but not the chicken), v-ets is homologous to sequences in two noncontiguous regions, one (c-ets-1) on chromosome 11, the other (c-ets-2) on chromosome 21 (de Taisne et al., 1984; Watson et al., 1985) . There is no homology between the two c-ets sequences except for a small overlap that encodes 14 amino acids, 12 of which are conserved between the two loci; both loci are transcribed in human cells (Watson et al., 1985) . There is no direct evidence implicating the c-ets sequences in human neoplasia, though the c-ets-1 gene has been localized to chromosome 1l(q23-24) (de Taisne et al., 1984) , a region in which a constitutive fragile site has been found (Yunis & Soreng, 1984) . There is, however, circumstantial evidence linking rearrangement of the c-ets domains with some human myeloid leukaemias and a lymphoma. First, Diaz et al. (1986) hybridized a v-ets probe to metaphase chromosomes from three patients with acute monocytic leukaemia, each of whom had a t(9; 1 1)(p22;q23), and demonstrated translocation of the c-ets-1 gene to the short arm of chromosome 9. However, no restriction fragment length polymorphisms of the c-ets-I gene could be found in leukocyte DNA from these patients. Second, analyses of panels of somatic cell hybrids derived from a human myeloid/lymphoid leukaemic cell line carrying the (4;11)(q21;q23) translocation showed that the c-ets-1 domain had been translocated from chromosome 11 to chromosome 4; similarly, translocation of c-ets-2 from chromosome 21 to chromosome 8 was found in acute nonlymphoblastic leukaemia (ANLL) cells (FAB class M2) with a t(8;21)(q22;q22) (Sacchi et al., 1986) . Again, however, Southern blot analyses failed to demonstrate rearrangement of c-ets sequences in DNAs from leukocytes of ANLL patients with either the (4; 11) or (8; 21) translocation. Third, rearrangement and amplification of c-ets-I sequences have been found in DNA from one ANLL (FAB class M4) in which there was a homogeneously staining region at llq23, and in DNA from a small lymphocytic cell lymphoma with an inversion at llq23 (Rovigatti et al., 1986) . Unspecified alterations in the c-ets-l locus in several other ANLLs with karyotypic abnormalities involving band 1lq23 have also been reported by Rovigatti et al. (1986) .
A t(4; 1 1)(q21;q23) is also associated with a sub-group of acute lymphoblastic leukaemias (ALL) (Arthur et al., 1982; Rowley & Testa, 1982; Mirro et al., 1986 7 ALLs for evidence of re-arranged c-ets-I sequences. Hybridization of a c-ets-1 probe (de Taisne et al., 1984) to Southern blots of electrophoretically fractionated Eco RIdigested normal peripheral blood leukocyte DNA (Figure 1 ) revealed the 8.6 kbp fragment homologous to c-ets-1 described previously (de Taisne et al., 1984) . The same 8.6 kbp fragment was found in the DNAs from all 7 ALLs, and two of them also showed extra c-ets-1-homologous fragments ( Figure 1 It is formally possible that we have detected amplified c-ets-related sequences in ALL/01 and ALL/04, in a manner analogous to that described for N-myc (Brodeur et al., 1984 . The c-ets-l probe was a 5.4 kbp human genomic fragment containing a sequence homologous to the 3' end of v-ets (Leprince et al., 1983; de Taisne et al., 1984) recloned in pKH47. in Eco RI-digested normal human DNA that hybridize weakly with a v-ets probe (de Taisne et al., 1984) . It is also possible that aberrant-sized c-ets-1-homologous fragments are due to naturally occurring restriction fragment length polymorphisms. We were unable to obtain non-leukaemic material from patients ALL/01 and ALL/04, both of whom were children. However, we did examine the pattern of c-ets-1 hybridization to Southern blots of Eco RI-digested DNA from normal tissues, myeloid leukaemias, lymphomas and cell lines, representing in total over 60 individuals, and in no case detected any c-ets-l homologous fragment apart from the germ-line 8.6kbp fragment (Jack et al., 1986 , and data not shown). In addition, aberrant-sized c-ets-1-homologous fragments were found in ALL/04 DNA digested with Bgl II, Hind III and Pvu II (Figure 2) , and Cla I (data not shown), but not in other DNAs (Figure 2) . Although similar analyses with ALL/01 DNA were not possible because of lack of material, we conclude that the abnormal c-ets hybridization patterns seen with Eco RI-digested DNAs from ALL/01 and ALL/04 (Figure 1 ) are due to rearrangement of c-ets-I sequences in the leukaemic cells from these patients.
Diagnoses, total leukocyte counts and karyotypes of the 7 ALL patients examined are summarized in Table I . Patients ALL/01 and ALL/04 both exhibited high leukocyte counts (about 200 x 1091-1) at presentation; 4 of the other 5 had leukocyte counts of less than 40 x 1091-. On the basis of morphological, cytochemical and immunological criteria, patient ALL/O1 was diagnosed as a T-cell ALL, FAB class LI/L2 and patient ALL/04 as a common ALL, FAB class L2. Chromosome analysis for two patients (unfortunately including ALL/01) was not available, and for four patients indicated an apparently normal karyotype. Leukaemic cells from patient ALL/04 showed a range of chromosome deletions and the presence of several unidentifiable marker chromosomes. The only consistent abnormality was deletion of one chromosome 11. However, because the chromosome morphology had the fuzzy appearance common in ALL karyotypes, it was not possible to determine whether there was a t(4; 11) that was masked by other translocations.
No rearrangements of c-ets-1 sequences were detected in (Rovigatti et al., 1986) . The detection of disparate sizes of aberrant c-ets-1-homologous fragments in Eco RI-digested DNA from the peripheral blood leukocytes from two ALLs implies that the position of the break-point in or near c-ets-I is variable. This situation is similar to that documented for c-myc in Burkitt's lymphoma (Bernard et al., 1983) and, in particular, for c-abl in Ph1-positive CGL in which break-points on chromosome 9 from 14 to 40kbp from the v-abl-homologous sequences have been found (Groffen et al., 1984) . Thus it is possible that we, and others, have failed to detect rearrangement of c-ets-1 in some cases because the probe used is not capable of detecting rearrangements involving break-points at some distance from the c-ets-I sequence. The only factor common to the two ALLs in whose leukocyte DNAs the rearrangements of c-ets-1 sequences were found is the marked leucocytosis at presentation, one noted feature of ALLs with t(4; 1 1)(q21 ;q23) (Arthur et al., 1982; Rowley & Testa, 1982) . It is unforunate, therefore, that no conclusion can be drawn from our data regarding a link between c-ets-I rearrangement and a (4; 11) translocation. However, it is possible that Southern blot analyses with c-ets-1 probes can reveal a subset of patients with (4; 11) translocations that are difficult to detect in ALL karyotypes because of typically unclear chromosome morphology and/or because they are masked by other translocations, in a way analogous to that described for masked Philadelphia translocations in CGL (Bartram et al., 1985) . If so, this preliminary report suggests that such analyses could provide important diagnostic information since ALLs with t(4; 1 l)(q21;q23) have a poor prognosis with conventional therapy (Arthur et al., 1982; Rowley & Testa, 1982; Mirro et al., 1986) .
